格隆汇1月13日丨昭衍新药(603127.SH)在互动平台表示，公司非人灵长类模型主要是自用，用于非临床 安评实验相关研究，不涉及脑机接口业务。 ...

Core Viewpoint - The A-share market has shown a strong upward trend since the beginning of 2026, driven by multiple factors including the technology cycle, policy benefits, economic recovery, and the return of overseas capital [1][3][4]. Group 1: Market Performance - As of January 12, 2026, the Shanghai Composite Index has achieved a "seventeen consecutive days" rise, with significant increases in trading volume and active capital inflow [1][3]. - The performance of various sectors shows that cyclical stocks, technology stocks, and military industry stocks have led the gains, while financial and consumer stocks have underperformed [1][3]. Group 2: Driving Factors - The dual momentum from technology and cyclical sectors has significantly enhanced risk appetite among investors, with the digital economy, particularly AI and semiconductors, leading the charge [3][4]. - The release of concentrated economic policies since the beginning of 2026, including a 625 billion yuan special bond for consumer upgrades, has contributed to the market's positive outlook [4][5]. - Economic recovery is gaining momentum, with manufacturing and non-manufacturing PMIs returning above the growth line, indicating a shift towards quality and efficiency in corporate operations [5][6]. Group 3: Capital Flows - The appreciation of the RMB against the USD has attracted overseas capital back to China, as global investors seek stable assets amid geopolitical uncertainties [6][7]. - Data indicates an increase in holdings of Chinese assets by global and Asian funds compared to the end of 2024, supported by targeted policies and growth in AI-related profits [7]. Group 4: Futures Market Dynamics - The narrowing of the basis in stock index futures indicates strong bullish sentiment among investors, with significant shifts in the annualized basis rates for various contracts [8][9]. - Recent fluctuations in futures contracts suggest a potential adjustment phase, with the cost of rolling over contracts decreasing, reflecting a more favorable position for investors [10][11]. Group 5: Future Outlook - The market is transitioning from valuation-driven growth to profit-driven performance, with individual stock performance increasingly tied to fundamental improvements and rising economic conditions [11][12]. - The A-share market is expected to continue its upward trajectory, supported by ongoing policy effects, enhanced economic recovery, and the sustained influx of overseas capital [12].

Core Viewpoint - The "brain-computer interface" has become a hot topic in the capital market, leading to significant stock price fluctuations and heightened regulatory scrutiny on companies involved in this sector [1]. Group 1: Company Actions and Regulatory Responses - Company Yahui Long announced a strategic cooperation with Shenzhen Brain Machine Star Chain Technology Co., Ltd., which has only been established for four months, to collaborate on product development and market promotion [2]. - Prior to the announcement, Yahui Long's stock price surged by 6.52%, with trading volume increasing by 299%, raising concerns about the timing of the announcement [2]. - Following regulatory pressure, Yahui Long issued a supplementary announcement retracting its previous statements, clarifying that the partner's products are still in early development stages and have not yet entered the registration phase [2][3]. - The Shanghai Stock Exchange issued a regulatory warning to Yahui Long for inconsistent disclosures regarding the technical capabilities of its partner, which violated listing rules [3]. Group 2: Financial Performance and Market Context - Yahui Long's financial performance has been under pressure, with a reported revenue of approximately 1.287 billion yuan for the first nine months of 2025, a year-on-year decline of 7.69%, and a net profit of 60.42 million yuan, down 72.36% [4]. - The company attributed its declining performance to reduced domestic market demand due to industry policies and losses from the fair value changes of financial assets [4]. - The Shanghai Stock Exchange requested Yahui Long to explain the rationale behind its cross-industry cooperation given its financial situation, emphasizing that the investment in Brain Machine Star Chain would not significantly impact its operations [4]. Group 3: Broader Industry Implications - Other companies, such as Yingjixin, also received regulatory warnings for misleading disclosures related to brain-computer interface technologies [5]. - Yingjixin claimed its IPA1299 chip is suitable for brain signal acquisition but later clarified that it is still in the market cultivation phase and has not achieved large-scale sales [6]. - Several other companies in the sector, including Weisi Medical and Xiangyu Medical, experienced stock price surges and subsequently issued risk warnings, stating that their brain-computer interface businesses are not their main operations and are still in early development stages [6].

Group 1 - The company, Shenglu Communication (002446.SZ), stated on its interactive platform that it has not collaborated with any companies related to brain-computer interfaces [1]

Core Viewpoint - Youke Technology (688158.SH) has established a strategic partnership with Brain Tiger Technology since 2022, focusing on the cloud processing of EEG data and exploring brain-computer interface technology applications in medical rehabilitation [1] Group 1: Strategic Partnerships - Youke Technology and Brain Tiger Technology, along with Fudan University Huashan Hospital, have been selected as members of the Shanghai Future Industry Brain-Computer Interface Expert Committee in 2023 [1] - The collaboration aims to jointly apply advanced capabilities in cloud computing, big data, and artificial intelligence to explore the medical applications of brain-computer interfaces [1] Group 2: Research and Development Initiatives - In 2024, Youke Technology and Brain Tiger Technology deepened their cooperation by participating in significant research project applications in the brain-computer interface field in Shanghai [1] - The partnership is focused on developing an "implantable speech synthesis brain-computer interface product" to assist patients with aphasia in regaining partial language functions [1] Group 3: Technological Infrastructure - Youke Technology has successfully built a GPU computing platform and a corpus data management system, leveraging its high-performance computing and reliable data storage capabilities [1] - As a leading neutral third-party cloud computing service provider in China, Youke Technology aims to efficiently provide intelligent computing to various industries while exploring AI application scenarios and commercial pathways [1]

Core Insights - The article discusses the rapid advancement and commercialization of brain-computer interface (BCI) technology in China, driven by policy support and significant capital investment [1][5][9]. Technological Breakthroughs - Recent breakthroughs in BCI technology include successful clinical trials for invasive systems, enabling high-level paraplegic patients to control devices like smart wheelchairs and robotic dogs [5][6]. - Companies like JieTi Medical and ChipSmart have made significant progress, with JieTi completing three invasive clinical trials and ChipSmart's semi-invasive product achieving successful human implants [5][6]. - The BCI technology is categorized into non-invasive, semi-invasive, and invasive types, each with its advantages and disadvantages [5]. Policy and Capital Support - The Chinese government has identified BCI as one of the six future industries in the 14th Five-Year Plan, providing a strategic framework for its development [8][9]. - Recent policy initiatives include the establishment of independent billing for BCI services by the National Medical Insurance Administration, with several provinces setting clear pricing for BCI medical services [8][9]. - The National Medical Products Administration has also initiated standards for BCI technology, which will help reduce costs and risks associated with clinical applications [8][9]. Market Opportunities - The BCI market is expected to grow significantly, with a focus on medical applications for conditions like stroke, epilepsy, and paralysis, where patients show a strong willingness to adopt early products [6][7]. - The integration of BCI technology with artificial intelligence and robotics could open up a trillion-dollar market space in the long term [11]. Industry Standardization - The BCI industry is anticipated to move towards standardization and scalability, with initial industry standards expected to be established by 2027-2028 [10]. - The domestic BCI industry benefits from strong policy support, a vast clinical resource base, and a complete supply chain, which are crucial for its growth [10]. Investment Landscape - Investment firms highlight the dual nature of BCI as both a medical and technology investment, emphasizing the importance of identifying policy-supported "true BCI" targets [11]. - The potential for leading Chinese BCI companies to emerge on the global stage is significant, given the country's advancements in technology and supportive investment environment [11].

Market Overview - The Hong Kong stock market showed a high open but low close, with cautious market sentiment. The Hang Seng Index rose by 0.9% to 26,848.47, while the Hang Seng Tech Index increased by 0.11% to 5,869.79, and the China Enterprises Index gained 0.71% to 9,285.41 [1][2]. Sector Performance - Technology stocks had mixed results, with Alibaba rising by 3.6% after previously increasing by 6.3%, while Kuaishou fell by 2.2%, and Xiaomi and Baidu dropped nearly 2% [2][4]. - Gold and precious metals surged, with spot gold reaching a new high of $4,630 per ounce and silver surpassing $86 per ounce, driven by geopolitical risks and concerns over the Federal Reserve's independence [6][7]. - Biopharmaceutical stocks were active, with WuXi AppTec rising over 8% following a positive earnings forecast, while other leading biopharma stocks also saw gains [7][8]. - Insurance stocks performed well, with China Pacific Insurance rising over 4% and China Life increasing by over 3% [11]. - Oil stocks generally rose, with CNOOC gaining over 2% and China Petroleum increasing by 1% [12]. - Automotive stocks saw broad increases, with Li Auto, Great Wall Motors, and Xpeng all rising over 2% [13]. Notable Stock Movements - WuXi AppTec projected a revenue of 45.456 billion yuan for 2025, a 15.84% increase year-on-year, with a net profit forecast of 19.151 billion yuan, reflecting a 102.65% increase [8]. - The AI healthcare sector saw significant gains, with Ark Health rising over 65% [9][10]. - Lithium battery stocks surged, with Zhongxin Innovation rising by 6.4% and Ganfeng Lithium increasing by nearly 4% [14][15]. - The commercial aerospace sector experienced a collective pullback, with Asia Pacific Satellite dropping over 9% [16]. - The brain-computer interface sector saw notable declines, with Nanjing Panda Electronics falling by 7.79% [18]. - The education sector faced widespread declines, with Minsheng Education dropping over 4% [22]. Capital Flows - Southbound funds recorded a net inflow of 1.296 billion HKD, with the Shanghai-Hong Kong Stock Connect contributing 149 million HKD and the Shenzhen-Hong Kong Stock Connect contributing 1.147 billion HKD [25]. Market Outlook - Analysts suggest that the Hong Kong stock market may continue to lag behind A-shares, with a need for time to restore investor sentiment. The market's future performance will likely be influenced by large financials, commodities, and internet sectors, with potential structural opportunities in undervalued stocks with resilient fundamentals [25].

Group 1 - The company, Shenglu Communication (002446.SZ), stated on its interactive platform that it has not collaborated with any companies related to brain-computer interfaces [1]

Core Viewpoint - Feirongda (300602.SZ) has stated that its products are not currently applied in the brain-computer interface field, but the company will actively monitor developments in related technology areas to enhance its competitive advantage [1]. Group 1 - The company is not involved in the brain-computer interface sector at this time [1]. - The company is committed to considering and evaluating any measures that could benefit its development [1]. - The focus is on continuously improving its overall competitive advantage [1].

格隆汇1月13日丨南京熊猫(600775.SH)在投资者互动平台表示，公司主营业务聚焦智慧交通与平安城 市、工业互联网与智能制造、绿色服务型电子制造三大领域，目前未发生任何变化。截至目前，公司尚 无与脑机接口相关的成熟产品，亦未形成相关销售收入。 ...